Twist Bioscience Corporation
TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital dā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$48.32
Price-8.74%
-$4.63
1Y
Price
Market Cap
$3.009b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-35.8%
EBITDA Margin-39.8%
Net Profit Margin-23.1%
Free Cash Flow Margin-35.8%
EBITDA Margin-39.8%
Net Profit Margin-23.1%
Free Cash Flow MarginRevenue
$409.479m
+8.7%
1y CAGR+18.9%
3y CAGR+19.3%
5y CAGREarnings
-$81.276m
-4.6%
1y CAGR+18.7%
3y CAGR+15.6%
5y CAGREPS
-$1.33
-2.3%
1y CAGR+20.5%
3y CAGR+18.1%
5y CAGRBook Value
$455.094m
$676.214m
Assets$221.120m
Liabilities$95.841m
DebtDebt to Assets
14.2%
-1.6x
Debt to EBITDAFree Cash Flow
-$95.140m
-25.8%
1y CAGR+8.1%
3y CAGR+12.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company